Eli Lilly (LLY) Dividends payables Growth (5y) (2014 - 2024)

Eli Lilly (LLY) Dividends payables Growth (5y) (2014 - 2024) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 14.93%
Jun 30, 2024 14.53%
Dec 31, 2023 12.43%
Jun 30, 2023 11.94%
Dec 31, 2022 11.49%
Jun 30, 2022 10.01%
Dec 31, 2021 10.07%
Jun 30, 2021 7.48%
Dec 31, 2020 7.41%
Dec 31, 2019 4.83%
Jun 30, 2019 2.53%
Dec 31, 2018 4.45%
Jun 30, 2018 1.87%
Dec 31, 2017 1.75%
Jun 30, 2017 0.14%
Dec 31, 2016 0.21%
Jun 30, 2016 -0.18%
Dec 31, 2015 -0.04%
Jun 30, 2015 -0.61%
Dec 31, 2014 -0.29%